Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,823.61
    -53.44 (-0.68%)
     
  • Bitcoin USD

    64,749.85
    +3,207.22 (+5.21%)
     
  • CMC Crypto 200

    1,334.22
    +21.60 (+1.67%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,397.20
    -0.80 (-0.03%)
     
  • Crude Oil

    83.38
    +0.65 (+0.79%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Why CTI BioPharma Stock Blasted 18% Higher Today

The stock of CTI BioPharma (NASDAQ: CTIC) was an outlier in the biotech sector on Thursday, and in the best way possible. The company's shares surged more than 18% higher on the day, following a new and bullish analyst note on the company based on positive anecdotal evidence. Peaker rates it an unequivocal outperform (read: buy), at a price target of $10 per share.